BOOTH DANIEL J

OHI COO Daniel J. Booth sold 56,725 shares at $40.25 on 2024-09-27, reducing holdings by 36.2%

Daniel J. Booth, COO of Omega Healthcare Investors, sold 56,725 shares at $40.25 for $2,283,181.25, reducing his holdings from 156,725 to 100,000 shares—a 36.2% reduction in position size. This represents a material divestiture that brings his remaining stake to 100,000 shares. The stock closed the transaction date within its 52-week range, 2.2% below the 52-week high of $41.29, and has appreciated 2.2% over 30 days and 19.5% over 90 days. While his cross-ticker track record shows 2 prior sells averaging +4.4% 30-day returns, his OHI-specific prior sales on 2024-09-05 and 2024-08-23 are still within their measurement windows with limited outcome data available. The fundamentals show a $10.4B market-cap company with $252.7M quarterly revenue, 8.1% annual revenue growth, and a P/E of 30.83—metrics suggesting reasonable operational performance. The substantial share reduction merits investor attention as a significant change in executive stake.

COO Daniel J Booth sold 25,000 shares of OHI at $40.06; holds 156.7K shares post-sale

Daniel J Booth, Chief Operating Officer, sold 25,000 shares at $40.06 on 2024-09-05, reducing his position from 181.7K to 156.7K shares (a 13.8% reduction). The sale occurred near the 52-week high of $39.99 and at a price above the current price of $39.64. Booth's cross-ticker track record shows 1 prior sell, with the outcome of prior sells at this specific ticker not yet measurable. The company reported $252.7M in latest quarterly revenue and $117.1M net income, with annual revenue growth of 8.1% and a P/E of 30.26. This is a standard open-market sale by a senior executive with a substantial continuing position; without measurable performance data on his prior OHI trades or broader timing patterns, the transaction does not present an unusual signal.

COO Daniel Booth sold 25,000 OHI shares at $38.71; holdings reduced to 181.7K shares

Daniel J Booth, Chief Operating Officer, executed an open-market sale of 25,000 shares at $38.71 on 2024-08-23, reducing his holdings from 206.7K shares to 181.7K shares—a -12.1% reduction in stake. The sale occurred near the company's 52-week high of $38.84, and the stock has appreciated 7.0% over the prior 30 days and 24.8% over 90 days, indicating strong recent momentum. The company's fundamentals remain solid with quarterly revenue of $252.7M, net income of $117.1M, annual revenue growth of +8.1%, and a market cap of $10.0B. This single discretionary sale by a key operating executive warrants monitoring to determine whether it reflects portfolio management or signals changing confidence in near-term prospects.